ResearcherFudan UniversityNo recent work listed

Chao Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0473-6608; OpenAlex author ID A5101406914. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Co-author DOI 10.1007/s13402-019-00435-1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianang Li · 1 shared paper, 2020 · strength 0.11
- Paper PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. DOI 10.1007/s13402-019-00435-1 ↗
Mengmeng Liu · 1 shared paper, 2020 · strength 0.11
- Paper PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. DOI 10.1007/s13402-019-00435-1 ↗
Yuan Fang · 1 shared paper, 2020 · strength 0.11
- Paper PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. DOI 10.1007/s13402-019-00435-1 ↗
Yefei Rong · 1 shared paper, 2020 · strength 0.11
- Paper PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. DOI 10.1007/s13402-019-00435-1 ↗
Wenhui Lou · 1 shared paper, 2020 · strength 0.11
- Paper PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. DOI 10.1007/s13402-019-00435-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.